IMMUNETHEP
Research - Cantanhede, Coimbra, Portugal
IMMUNETHEP Employees
IMMUNETHEP Senior Management
IMMUNETHEP Details
Immunethep is a biotech startup company (spin-off from the University of Porto) that is developing anti-bacterial immunotherapies based on the discovery of a virulence mechanism shared by different bacteria that cause life-threatening infections.The first product, PNV1 - Paragon Novel Vaccine, is a preventive strategy that will confer a robust protection against the main life threatening bacterial infections, including multi-resistant strains. PNV1 will be the first vaccine able to prevent multi-bacterial infections from all its serotypes from the womb until elderhood.
Website:
http://www.immunethep.com
Employees:
16
HQ:
351 23 141 0890
Location:
Cantanhede, Coimbra, Portugal
Revenue:
1M
IMMUNETHEP Technologies
Load Balancers
Nginx
Other
Mobile Friendly
CSS and JavaScript Libraries
Bootstrap Framework